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Abstract 
The transcription factor Nuclear factor one X (NFIX) plays a central role during the 
development of the neocortex and hippocampus, through the activation of astrocyte-
specific gene expression and the repression of progenitor-specific pathways. 
However, our understanding of transcriptional targets of NFIX during cortical 
development remains limited. Here we identify the transcription factor Bobby sox 
(Bbx) as a target for NFI-mediated transcriptional control. BBX is expressed within 
ventricular zone progenitor cells within the developing neocortex and hippocampus, 
and its expression is upregulated in Nfix-/- mice. Moreover, we reveal that NFIX can 
repress Bbx promoter-driven expression. Collectively, these data suggest that Bbx is a 
downstream target of NFIX during development of the forebrain.  
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Introduction 
The transcription factors of the NFI family (NFIA, NFIB, NFIC and NFIX) are 
emerging as important regulators of neural development. NFIX is expressed widely 
within the developing brain, including within the ventricular zone and dentate gyrus 
of the embryonic hippocampus, and Nfix-/- mice exhibit abnormal development of the 
neocortex, hippocampus and cerebellum (Campbell et al., 2008; Piper et al., 2011). At 
a mechanistic level, NFIX has been shown to promote the expression of astrocyte-
specific genes in human glioblastoma-derived cell lines (Brun et al., 2009), and to 
repress expression of the progenitor cell-specific gene Sox9 in vivo (Heng et al., 
2013). As such, mice lacking Nfix exhibit prolonged progenitor cell self-renewal, 
concomitant with delayed neuronal and glial differentiation within the hippocampus 
and neocortex (Heng et al., 2013).  
 
Despite these findings, our understanding of the genes regulated by NFIX during 
development of the forebrain remains limited. To identify further potential targets of 
NFIX we used a multifaceted approach. Firstly, we mined a recently published 
microarray performed on the hippocampus of embryonic day (E) 16 Nfix-/- mice to 
identify transcription factors that were misregulated in the mutant mice (Heng et al., 
2013). We then ascertained if potential targets were expressed within the developing 
forebrain using gene expression data within the Allen Brain Atlas. Finally, we used an 
in silico bioinformatic approach to identify whether these putative NFIX target genes 
contained an NFI binding motif close to their transcription start site. This analysis 
identified Bobby sox (also called Hbp2) as a potential target downstream of NFIX. 
Here we reveal that BBX is expressed by neural progenitor cells within the 
developing neocortex and hippocampus, and that there are significantly more cells 
expressing BBX in the neocortical and hippocampal ventricular zone of E16 Nfix-/- 
mice. Finally, we demonstrate that NFIX can regulate Bbx-promoter driven 
transcriptional activity, suggestive of NFIX regulating Bbx transcription during 
forebrain development. 
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Methods 
Mouse strains 
C57Bl/6J Nfix+/+ and Nfix-/- littermate mice were used in this study. Animals were 
bred at the University of Queensland under approval from the institutional Animal 
Ethics Committee.  
 
Immunohistochemistry 
Immunohistochemistry  using  the  chromogen  3,3’  diaminobenzidine  on  floating  
vibratome sections (50 μm) was performed as described previously (Heng et al., 
2013) using a rabbit-anti-BBX antibody (Abcam, ab94418, 1/10,000). 
Immunohistochemistry was performed on 6 μm  paraffin  sections  as  described  
previously (Barry et al., 2008) using the anti-BBX antibody (1/1,000). For all 
immunohistochemical analyses, at least 5 littermate wild-type and Nfix-/- brains were 
analyzed. Sections from comparable positions along the rostrocaudal axis were 
imaged using an upright microscope (Zeiss upright Axio-Imager Z1) fitted with an 
Axio-Cam HRc camera. For counts of BBX-positive cells within the ventricular zone 
of the neocortex and hippocampus, the number of immunopositive cells per 100 m 
of ventricular zone was quantified using images of immunohistochemically labelled 
paraffin sections at E16. For all experiments, data represent pooled results from at 
least 5 wild-type and 5 Nfix-/- brains. Counts were performed blind to the genotype of 
the sample. Statistical analyses were performed using a two-tailed unpaired t-test. 
Error bars represent the standard error of the mean. 
 
Immunofluorescence staining 
Immunofluorescence staining was performed on 6 μm  paraffin  sections  using  the  
BBX antibody (1/500) and a mouse-anti-nestin antibody (Developmental Studies 
Hybridoma Bank, rat-401, 1/100). The secondary antibodies used were a goat-anti 
mouse IgG Alexa 488 and a goat-anti-rabbit IgG Alexa 594 (Invitrogen; both 1/500). 
Images were obtained using an upright microscope (Zeiss upright Axio-Imager Z1). 
 
Bioinformatic promoter screen 
The NFI binding motif was generated as reported previously (Heng et al., 2013) from 
published chromatin immunoprecipitation-sequencing (ChIP-seq) data for NFI (pan-
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NFI antibody used) (Pjanic et al., 2011). The DNA-binding domains of all NFI 
proteins are highly similar (Mason et al., 2009). In brief, we performed motif 
discovery using the MEME algorithm (Bailey et al., 2009) on ChIP-seq peaks 
redeclared using the ChIP-Peak algorithm (Schmid and Bucher, 2010) from the 
published ChIP-seq  “tag”  data  for  NFI.  We  then  identified  potential  NFI  binding  sites  
by scanning the complete mouse genome downloaded from the UCSC Genome 
Browser (mm9, July 2007) (Fujita et al., 2011) using the MEME-derived motif and 
the FIMO motif-scanning program (Grant et al., 2011).  FIMO was run on the mouse 
genome (without repeat masking) using a 0-order background generated on the entire 
mouse genome, and a pseudocount of 0.1. All potential binding sites with p-value  ≤  
10-4 were reported. The putative NFI binding sites near the promoter of Bbx 
(chr16:50437453-50437467) were identified manually by viewing the FIMO output 
using the UCSC genome browser. We identified two potential sites upstream of the 
transcription start site (-4951 and -5758 relative to the transcription start site) and one 
downstream of the transcription start site (+222). We focussed on the first site 
upstream of the transcription start site for further analysis. To search for other 
potential transcription factor binding sites within the Bbx promoter, we searched the 
region around the transcription start site of Bbx (-6000 to +1000 base pairs) using 
FIMO and the SELEX motifs from Jolma et al. 2013 (Jolma et al., 2013), the 
UniPROBE mouse motifs (Newburger and Bulyk, 2009) and the JASPAR vertebrate 
motifs (Sandelin et al., 2004).  Collectively these data provide a total of 1271 
potential motifs. We identified 2692 predicted sites within this region at an 
(unadjusted) p-value threshold of 10-4. To refine this list, we narrowed our screen to 
sites with FIMO p < 10-6 that were within 250 base pairs either side of the putative 
NFI site located at -4951. This revealed two additional motifs, namely for the proteins 
Gm397 (-4754) and ZFP281 (-5208). 
 
Electrophoretic mobility shift assay 
Electrophoretic mobility shift assays were performed using radiolabeled annealed 
oligonucleotides as described previously (Heng et al., 2013). Nuclear extracts were 
isolated from COS cells expressing an HA-tagged NFIX expression construct or an 
HA-tagged AP2 expression construct.  Oligonucleotide sequences were: Bbx upper – 
5’-
CCGGGTGAGTGAGGCCTCCTTGGGCTCTTCCCCATCCACATTAACTTGTTC-
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
3’;;  Bbx lower 5’-
CCGGGAACAAGTTAATGTGGATGGGGAAGAGCCCAAGGAGGCCTCACTC
AC-3’. 
 
Luciferase assay 
The constructs used in the luciferase assay were an NFIX expression construct and a 
construct containing 942 base pairs of the upstream promoter of Bbx (from -4426 to -
5368 relative to the transcription start site) that included the putative NFI binding site 
at -4951 cloned into the pGL4.23 vector (Promega). DNA was transfected into 
Neuro2A cells. A Renilla luciferase vector was added to each transfection as a 
normalization control. After 48 hours, luciferase activity was measured using a dual 
luciferase system (Promega). Within each experiment, each treatment was replicated 
6 times. Each experiment was also independently replicated a minimum of three 
times. Statistical analyses were performed using an ANOVA with a post hoc Tukey’s  
test. Error bars indicate the standard error of the mean.  
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Results  
Microarray analysis performed on the hippocampus of littermate E16 Nfix+/+ and Nfix-
/- mice has previously identified over 1000 genes as being differentially expressed 
within the mutant, with over 65 transcription factors being upregulated (Heng et al., 
2013). To determine which of these may be putative NFIX targets as assessed by 
being expressed in the same brain regions as NFIX, we first interrogated the mRNA 
expression profiles of these genes within the Allen Brain Atlas. One gene whose 
expression pattern within the nascent forebrain was highly specific was the 
transcription factor Bbx, a member of the SOX (Sry-related HMG box) family. Bbx 
showed a specific pattern of expression within the emerging forebrain, being 
expressed by progenitor cells within the ventricular zone of the embryonic neocortex 
and hippocampus (http://developingmouse.brain-map.org, search reference Bbx) at 
E15.5. To more clearly delineate the expression of this factor in the developing 
forebrain, we analysed the expression of BBX in the forebrain at a protein level using 
immunohistochemistry on 6 μm  paraffin  sections.  At E14, expression of BBX was 
clearly evident within the nuclei of cells in the neocortical and hippocampal 
ventricular zone (Fig. 1A-E). Furthermore, co-immunofluorescence staining with the 
neural progenitor cell marker nestin revealed that BBX expressing nuclei within the 
ventricular zone were surrounded by nestin-positive fibres, suggesting that progenitor 
cells within the ventricular zone do indeed express BBX (Fig. 1F-H). At E16, 
expression of BBX within the hippocampus was more widespread, with ventricular 
zone progenitor cells and cells within the subventricular zone and intermediate zone 
expressing this transcription factor. Moreover, cells within the dentate migratory 
stream were also immunoreactive for BBX (Fig. 1I-L). Together, these findings 
suggest that BBX plays a role in forebrain development. 
 
We next investigated the expression of BBX within the cortex of E16 Nfix-/- mice. In 
line with our previous microarray data, we observed using 50 μm coronal brain 
sections that the expression of BBX within the ventricular zone of the neocortex and 
hippocampus of Nfix-/- mice was elevated when compared to littermate controls (Fig. 
2A, B). To quantify this, we performed immunohistochemistry against BBX on 6 μm  
paraffin sections and counted the number of immunopositive cells within the 
ventricular zone of the neocortex and hippocampus of wild-type and mutant brains 
(Fig. 2C-F). We found significantly more neocortical and hippocampal ventricular 
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zone cells expressing BBX within the mutant (Fig. 2G), suggesting that this 
transcription factor is a target for transcriptional repression by NFIX during 
development.  
 
To ascertain whether Bbx was a direct target for transcriptional regulation by NFIX, 
we next performed an in silico bioinformatic screen of the Bbx promoter, looking for 
putative NFI binding sites. This revealed three potential NFI binding sites near the 
Bbx transcription start site (Fig. 3A). We focussed on the first site upstream of the 
transcription start site, as this was predicted in silico to have a high probability of 
being a bona fide binding site (Fig. 3B). Moreover, scanning around this putative NFI 
site also identified potential DNA binding motifs for the transcription factors Gm397 
and ZFP281 (Fig. 3A). The latter has been implicated in controlling the pluripotency 
of embryonic stem cells (Wang et al., 2008), suggestive of this region of the Bbx 
promoter being important for the expression of Bbx in vivo. To assess the functional 
relevance of the predicted NFI site at -4951, we performed electrophoretic mobility 
shift assays using nuclear extracts from NFIX-expressing COS cells. Oligonucleotide 
probes encompassing the genomic region containing the putative NFI site at -4951 
were bound by a molecule within the nuclear extract (Fig. 3C). Using an anti-HA 
antibody (the NFIX expression construct carries a HA-tag), we further demonstrated a 
decrease in the mobility of the bound oligonucleotide in a supershift assay (Fig. 3C), 
suggesting that NFIX can directly bind to this site within the Bbx promoter. Finally, 
we performed a reporter gene assay, using a luciferase construct under the regulatory 
control of a 942 base pair fragment of the Bbx promoter that included the NFI motif at 
-4951. NFIX was able to repress luciferase expression controlled by the Bbx promoter 
fragment (Fig. 3D). Collectively, these data suggest that NFIX can repress the 
transcription of Bbx. 
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Discussion 
NFIX has been shown to regulate multiple aspects of nervous system development, 
including repressing progenitor-specific genes such as Sox9 during embryonic cortical 
development (Heng et al., 2013) and activating the expression of glial-specific genes 
such as Gfap, brain fatty acid binding protein and Ykl-40 within cultured cells in vitro 
(Brun et al., 2009; Singh et al., 2011). Here, we demonstrate that NFIX also regulates 
the expression of the novel transcription factor Bbx during cortical development, 
revealing another facet of the program through which NFIX modulates corticogenesis.  
 
BBX is strongly expressed by ventricular zone neural progenitor cells within the 
cortex, and significantly more cells expressing this transcription factor are found in 
the ventricular zone of Nfix-/- mice. An alternative explanation for the phenotype 
observed here is that the increase in cell numbers is the result of post-mitotic neurons 
failing to migrate away from the ventricular zone. However, we consider this 
unlikely, as our studies on different Nfi mutant strains has revealed that a key role for 
these transcription factors is to promote neural progenitor cell differentiation within 
the forebrain, and that in their absence, the production of post-mitotic progeny is 
significantly delayed (Barry et al., 2008; Piper et al., 2010). For example, we have 
recently shown that neural progenitor cell differentiation is delayed within the 
hippocampus and neocortex of Nfix-/- mice at E16, with resulting delays in forebrain 
neurogenesis being evident (Heng et al., 2013). Rather, our findings here point to 
BBX-expressing ventricular zone progenitor cells being more prevalent in the absence 
of NFIX. As NFIX is postulated to drive progenitor cell differentiation within the 
embryonic forebrain (Heng et al., 2013), these data suggest that BBX may promote 
progenitor cell self-renewal. However, the means by which BBX functions in this 
regard is currently unclear. BBX is a member of the SOX family of transcription 
factors, many of which have been implicated in neural progenitor cell self-renewal 
(Bani-Yaghoub et al., 2006; Scott et al., 2010), indicating that BBX may play a 
functionally analogous role developmentally. Moreover, BBX has been reported to 
bind DNA and to promote the G1/S phase transition in yeast (Sanchez-Diaz et al., 
2001), providing further evidence of a role for this transcription factor in cell cycle 
progression. 
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Interestingly, Bbx knockout mice have been generated by the European Conditional 
Mouse Mutagenesis Program (Friedel et al., 2007). Although these mice exhibit some 
phenotypic abnormalities, such as altered heart weight, analysis of the nervous system 
of postnatal knockout mice (at 6 and 16 weeks) did not reveal any gross 
morphological abnormalities using cresyl violet staining 
(http://www.sanger.ac.uk/mouseportal/phenotyping/MAEZ/mp-report/nervous-
system/). These findings do not, however, rule out a role for BBX during forebrain 
development, and future studies aimed at analyzing cortical neural progenitor cell 
self-renewal and their subsequent neuronal and glial differentiation during the period 
of corticogenesis may reveal deficits that will help elucidate the role of this 
transcription factor within the embryonic brain.  
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Figure Legends 
Figure 1. Expression of BBX in the developing hippocampus. 
A-E, Coronal paraffin section (6 μm)  of an E14 brain showing the expression of BBX 
via immunohistochemistry (IHC). BBX was strongly expressed within the ventricular 
zone of the neocortex (arrowhead in A) and hippocampus (arrow in A). B, BBX is 
expressed by cells within the ventricular zone of the hippocampus (arrow in B). C is a 
magnified view of the boxed area in B, revealing the nuclear localisation of BBX 
within ventricular zone cells of the hippocampus. D, BBX is also expressed by 
ventricular zone cells within the neocortex. E, At E14, there is no immunoreactivity 
for BBX within the developing thalamus. F-H, Co-immunofluorescence staining of a 
coronal 6 μm   paraffin   section   reveals   that   BBX-expressing nuclei within the 
hippocampal ventricular zone (F) are surrounded by nestin-expressing fibres (G), 
suggesting that neural progenitor cells express BBX (arrowheads in F, H). I-L, 
Coronal paraffin section (6 μm)  of an E16 brain showing the expression of BBX (I). 
BBX is expressed by cells within the neocortical ventricular zone (nVZ; arrowheads 
in J) and the hippocampal ventricular zone (hVZ; arrows in J) at this age, but also by 
cells within the dentate migratory stream (arrows in K) and by cells within the 
subventricular zone and intermediate zone (arrows in L). Scale bar (in L): A 600 m; 
B 300 m; C-E, 50 m; F-H 25 m; I, 250 m; J-L, 75 m.  
 
Figure 2. BBX expression is upregulated in the forebrain of Nfix-/- mice at E16. 
 A, B, Coronal vibratome sections (50 μm) of E16 wild-type and Nfix-/- brains, 
showing the expression of BBX. There were more cells in the hippocampal and 
neocortical ventricular zone of the mutant expressing BBX (arrows in B) than within 
the control (arrowheads in A). Coronal paraffin sections (6 μm)  of  wild-type (C, E) 
and Nfix mutant (D, F) brains processed for immunohistochemistry against BBX. 
There were significantly more cells expressing BBX within the neocortical and 
hippocampal ventricular zone of the mutant (arrows in D, F) than the control 
(arrowheads in C, E) at this age (G). VZ = ventricular zone. ** p < 0.01, t-test. Scale 
bar (in F): A, B, 600 m; C-F, 75 m. 
 
Figure 3. NFIX can repress Bbx-promoter driven transcriptional activity.  
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A, Schematic of the Bbx promoter, showing the three predicted NFI binding sites 
reported by FIMO. We focussed on the first site upstream of the transcription start 
site, at -4951. The zoomed up region of the Bbx promoter shown below depicts the 
two putative DNA binding motifs in the vicinity of the -4951 site, namely binding 
motifs for Gm397 and ZFP281. Also shown is the region of the promoter used in the 
luciferase assay (Bbx luc construct, grey rectangle). B, Sequence of the NFI binding 
site reported by FIMO at -4951 base pairs upstream of the Bbx transcription start site. 
The NFI binding motif used within the genome-wide scan is also shown. C, Nuclear 
extracts from COS cells expressing an HA-tagged AP2 construct (lanes 1 and 2) or an 
HA-tagged NFIX construct (lanes 3 and 4) were used in an electrophoretic mobility 
shift assay. The extracts were incubated with a radiolabeled probe containing the -
4951 site. Whereas the non-specific transcription factor AP2 did not demonstrate any 
specific binding to the oligonucleotide probe, the nuclear extract from the NFIX-
expressing cells exhibited significant binding to the probe (asterisk, lane 3). 
Moreover, the addition of an anti-HA antibody to the binding reaction depleted this 
complex and produced a supershifted complex (SS; lane 4). FP = free probe. D, 
Transfection of Neuro2A cells with an Nfix expression vector (Nfix pCAGIG) elicited 
no luciferase activity in a reporter gene assay, whereas transfection of a luciferase 
construct under the control of the Bbx promoter element elicited robust induction of 
the reporter gene. Co-transfection of Nfix with the Bbx promoter reporter yielded a 
significantly reduced level of luciferase activity. ** p < 0.01, ANOVA. 
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